Report Company Directory

WUXI ACRYL TECHNOLOGY CO LTD

• China Healthcare: Outperformers empowered by AI revolution. by UOB
• China Healthcare: CRDMO leaders take a temporary reprieve, aiming faster growth in 2025. by UOB

WuXi AppTec Co. Ltd. Class A

• WuXi AppTec (2359 HK): 2025: Results Beat; Targets Resilient Revenue Growth In 2026. by UOB
• Greater China Daily: Wednesday, March 25, 2026 by UOB
• Quick Note - Wuxi Apptec (603259 CH) (Buy) - CNY51.3-53.0bn revenue guided for FY26E by Nomura Research
• Quick Note - Wuxi Apptec (2359 HK) (Buy) - CNY51.3-53.0bn revenue guided for FY26E by Nomura Research
• China Healthcare Bi-Weekly: Resilient Innovation Amid Weak Market Sentiment. by UOB
• Regional Morning Meeting Notes: Monday, March 16, 2026 by UOB
• China Healthcare Bi-Weekly: Competing On The Global Stage Amid Rising Geopolitical Risks. by UOB
• Regional Morning Meeting Notes: Monday, February 16, 2026 by UOB
• Healthcare - Bi-Weekly: Poised For Strength by UOB
• Healthcare - Internet Healthcare: Evolving Amid AI Innovation And Policy Breakthroughs by UOB

WuXi AppTec Co. Ltd. Class H

• WuXi AppTec (2359 HK): 2025: Results Beat; Targets Resilient Revenue Growth In 2026. by UOB
• Greater China Daily: Wednesday, March 25, 2026 by UOB
• Regional Morning Meeting Notes: Wednesday, March 25, 2026 by UOB
• China Healthcare Bi-Weekly: Resilient Innovation Amid Weak Market Sentiment. by UOB
• Regional Morning Meeting Notes: Monday, March 16, 2026 by UOB
• China Healthcare Bi-Weekly: Competing On The Global Stage Amid Rising Geopolitical Risks. by UOB
• Regional Morning Meeting Notes: Monday, February 16, 2026 by UOB
• Healthcare - Bi-Weekly: Poised For Strength by UOB
• Healthcare - Internet Healthcare: Evolving Amid AI Innovation And Policy Breakthroughs by UOB
• Healthcare - Bi-Weekly: Stay Focused On Innovation by UOB

WUXI AUTOWELL TECHNOLOGY CO LTD

Wuxi Biologics (Cayman) Inc.

• First Read: Wuxi Biologics "H225 in line; conservative 2026 revenue..." by UBS AG
• China CRO Sector "H225 Preview: beyond prelim, what are the expectations..." by UBS AG
• Global Strategy "Quantamental Signal Ideas - Top & Bottom Ranked Stocks" Le Roux by UBS AG
• DOTTIKON ES Group "Swiss CDMO pure-play in small molecules - high-growth..." by UBS AG
• European Pharmaceuticals "US Formulary Access: Proprietary insights" Weston by UBS AG
• European Pharmaceuticals "Investor Pulse - February 2026" Weston by UBS AG
• China Equity Strategy "From de-risking to diversification: US investors'..." by UBS AG
• Wuxi Biologics (Cayman) Inc: 1 director by SmartInsider
• US Pharmaceuticals & Biotechnology ""All-Access Pass" Pharma / Biotech... by UBS AG
• Global Strategy "Quantamental Signal Ideas - Top & Bottom Ranked Stocks" Le Roux by UBS AG